Hemoglobin A1c and fasting plasma glucose measure different biological aspects of blood sugar regulation across entirely different time horizons. At Longevity Benchmark, we examine clinical guidelines and diagnostic literature to clarify how physicians interpret these two laboratory markers.
Neither test is universally superior. Discordance between the two values provides informative diagnostic context regarding underlying metabolic status or red blood cell dynamics.
The Verdict
HbA1c vs Fasting Plasma Glucose Side by Side
| Attribute | HbA1c | Fasting plasma glucose |
|---|---|---|
| Biological measurement | Percentage of red blood cell hemoglobin chemically bound to glucose | Concentration of free glucose circulating in blood plasma |
| Time window covered | Approximately three months, weighted toward the most recent weeks | A single moment in time after an overnight fast |
| Fasting requirement | No fasting required prior to blood collection | Requires a fasting period before the draw |
| Normal reference range | Below 5.7 percent | Below 100 mg/dL |
| Prediabetes diagnostic band | 5.7 percent to 6.4 percent | 100 to 125 mg/dL |
| Diabetes diagnostic threshold | 6.5 percent or higher | 126 mg/dL or higher |
| Day-to-day variability | Low biological variability across consecutive days | Moderate to high variability depending on sleep, stress, and fasting duration |
| Primary causes of unreliability | Hemoglobin variants, altered red blood cell lifespan, pregnancy, and G6PD deficiency | Acute illness, emotional stress, poor sleep, or incorrect fast duration |
| Diagnostic repetition standard | Requires confirmation on a separate day unless classic symptoms accompany elevated levels | Requires confirmation on a separate day unless classic symptoms accompany elevated levels |
| Next clinical step for discordant results | Evaluate red blood cell kinetics, assay interferences, or postprandial glucose excursions | Confirm the fasting period, repeat on a second day, or check daytime glycemia |
What Each Test Physically Measures
Glycated hemoglobin measures the proportion of hemoglobin proteins in red blood cells that have glucose attached to them. When circulating sugar moves through the bloodstream, it binds spontaneously to hemoglobin via non-enzymatic glycation. Because red blood cells survive for roughly three months, an HbA1c test reflects cumulative glucose exposure across that entire window. The reading weighs more heavily toward the most recent weeks of cell life. It requires no fasting beforehand. Our dedicated guide to HbA1c testing covers what this biomarker reflects and how clinicians evaluate chronic glycation.
Fasting plasma glucose (FPG) assesses free glucose concentration in venous blood at a single moment. The measurement requires a fasting period before the draw, typically scheduled in the morning. This value reflects immediate hepatic glucose output, peripheral insulin sensitivity, and overnight pancreatic beta-cell regulation. While HbA1c tracks a rolling three-month biological average, fasting plasma glucose acts as a snapshot of one morning.
Diagnostic Thresholds and Repeat Testing Rules
Clinical practice follows specific diagnostic boundaries published by the American Diabetes Association (ADA). For glycated hemoglobin, an HbA1c below 5.7 percent defines normal glycemic status. The prediabetes range spans 5.7 percent to 6.4 percent, while an HbA1c of 6.5 percent or higher meets the threshold for diabetes. For fasting plasma glucose, a result below 100 milligrams per deciliter (mg/dL) sits in the normal reference range. A fasting value from 100 to 125 mg/dL indicates prediabetes, and a concentration of 126 mg/dL or higher reaches the diabetes threshold.
Clinicians do not typically assign a permanent diagnosis based on a single isolated blood test. The ADA diagnosis criteria specify that each test usually needs to be repeated on a second day to diagnose diabetes. A physician can confirm diabetes from a single blood draw only if blood glucose is very high or if classic symptoms of hyperglycemia accompany the laboratory finding. The ADA criteria also recognize an oral glucose tolerance test (OGTT) 2-hour value below 140 mg/dL as normal, 140 to 199 mg/dL as prediabetes, and 200 mg/dL or higher as diabetes. Furthermore, a random plasma glucose concentration of 200 mg/dL or higher meets diagnostic criteria when severe symptoms occur.
Biological Reasons the Two Numbers Disagree
Discordance between HbA1c and fasting plasma glucose occurs because they measure distinct physiological processes across different time scales. A patient might present with a normal HbA1c alongside an elevated fasting plasma glucose reading, or conversely, an elevated HbA1c with normal fasting blood sugar. These variations stem from differences in red blood cell turnover, individual glucose kinetics, and acute behavioral factors.
In a 2024 study by Wang and colleagues published in PLoS One, researchers evaluated glycemic traits in 3,122 rural Chinese older adults without previously diagnosed diabetes. The study identified an optimal HbA1c cut-off of 6.5 percent (48 mmol/mol) for defining diabetes against fasting plasma glucose, with a sensitivity of 88.9 percent and a specificity of 93.7 percent. The correlation coefficient between fasting plasma glucose and HbA1c was 0.574, and the kappa statistic for defining diabetes reached 0.812. That investigation examined one specific cohort, and agreement statistics vary across different populations. The two tests identify overlapping but not identical populations with dysglycemia, which is why clinical guidelines maintain both as separate diagnostic options.
Postprandial glucose excursions can also drive discordance. If blood sugar spikes significantly after meals but returns to normal overnight, fasting plasma glucose remains low while HbA1c rises. Readers tracking these patterns often compare their values against normal versus optimal reference ranges.
Clinical Situations Where A1C Is Unreliable
Glycated hemoglobin relies on predictable red blood cell survival to estimate average blood sugar. The ADA Standards of Care in Diabetes 2026, Section 2, states that in conditions with an altered relationship between A1C and glycemia, plasma glucose criteria should be used to diagnose diabetes. These conditions include pregnancy, human immunodeficiency virus (HIV) infection, glucose-6-phosphate dehydrogenase (G6PD) deficiency, certain hemoglobin variants, and medical states that alter red blood cell turnover.
Red blood cell lifespan directly influences the percentage of glycated hemoglobin regardless of ambient blood sugar. Anything that shortens red blood cell lifespan lowers HbA1c because cells exit circulation before accumulating expected glucose attachments. Conversely, conditions that lengthen red blood cell survival allow excess glycation time, artificially raising HbA1c. Our review of false A1C results details these non-glycemic interferences.
- Hemoglobin variants. Some hemoglobin variants interfere with specific assay methods. Most assays used in the United States remain accurate for individuals heterozygous for common variants. However, HbA1c cannot be measured in people with sickle cell disease (HbSS) or other homozygous hemoglobin variants such as HbEE because their red blood cells lack hemoglobin A.
- Altered red blood cell turnover. Anything that shortens red-cell lifespan lowers A1C without glucose having changed, and anything that lengthens it raises A1C.
- Specific systemic conditions. Pregnancy alters red blood cell kinetics and plasma volume, requiring plasma glucose criteria for diagnostic accuracy. Glucose-6-phosphate dehydrogenase deficiency and HIV infection also disrupt the standard relationship between ambient glucose and hemoglobin glycation.
Factors That Skew a Single Fasting Glucose Draw
Fasting plasma glucose captures only the exact concentration of sugar present at the moment of venipuncture. Because circulating glucose fluctuates continuously, a single fasting reading is susceptible to acute physiological and behavioral variables. Acute psychological stress, poor sleep the preceding night, recent illness, or intense exercise can trigger counter-regulatory hormones like cortisol and epinephrine. These hormones stimulate the liver to release glucose, producing a transient spike that does not reflect underlying baseline regulation.
Fasting duration also alters the result. An unintended fast length changes what the number represents, which is one reason a single fasting value is repeated before a diagnosis is made. Patients can verify trends with an at-home A1C test or professional laboratory panels. Understanding the difference between acute glucose spikes and prolonged metabolic shifts helps clarify why clinicians require a second confirmatory test before rendering a formal diagnosis.
How Clinicians Evaluate Discordant Lab Results
When a lab report reveals one normal metric and one elevated metric, guidelines advise investigation rather than picking a favorite test. The ADA Standards of Care in Diabetes 2026 explicitly recommends that when there is consistent and substantial discordance between blood glucose values and A1C results, clinicians should evaluate for a problem or interference with either test. A discordant result is not an error. It provides valuable clinical information that points toward specific biological mechanisms.
If fasting glucose is elevated while HbA1c is normal, the ADA Standards of Care in Diabetes 2026 ask for interference with either test to be evaluated, and the published criteria ask for the fasting value to be repeated on a second day. If HbA1c is elevated while fasting glucose stays under 100 mg/dL, the clinician may assess post-meal glucose spikes, daytime dietary carbohydrate load, or red blood cell longevity issues. Evaluating both tests allows clinicians to distinguish between isolated fasting dysfunction and systemic three-month exposure. Readers working to address these patterns can examine our prediabetes reversal guide.
Additional Biomarkers for Glycemic Assessment
When HbA1c and fasting plasma glucose leave diagnostic ambiguity, clinicians turn to complementary biomarkers to complete the metabolic picture. The oral glucose tolerance test measures the 2-hour glucose value, which the ADA reads as normal below 140 mg/dL, prediabetes at 140 to 199 mg/dL, and diabetes at 200 mg/dL or higher. This test captures impaired glucose tolerance that fasting tests miss entirely.
Fasting glucose and HbA1c also do not measure circulating insulin. A patient can maintain normal blood glucose for years if their pancreas compensates by hypersecreting insulin. Clinicians frequently order fasting insulin to calculate HOMA-IR (homeostatic model assessment of insulin resistance). Evaluating these markers illuminates the boundary between insulin resistance versus prediabetes and reveals early signs of insulin resistance before fasting glucose or HbA1c crosses clinical thresholds. Some individuals also track continuous glucose monitoring data, though readers must consider CGM accuracy and assay differences when comparing sensor values to laboratory venous blood draws.
Frequently Asked Questions
Which is more accurate, A1C or fasting glucose?
Neither test is universally more accurate because they measure entirely different physiological phenomena. Fasting plasma glucose provides an exact measurement of free circulating glucose at a single moment after an overnight fast. Glycated hemoglobin reflects average glucose exposure across roughly three months by measuring sugar attached to red blood cells. A 2024 study by Wang and colleagues in rural Chinese older adults observed an 88.9 percent sensitivity and 93.7 percent specificity for HbA1c defining diabetes against fasting glucose, but agreement varies across populations. Fasting glucose can be distorted by acute morning stress, while HbA1c can be skewed by red blood cell lifespan. Clinicians rely on both markers together to form an accurate assessment.
Why is my A1C normal but my fasting glucose high?
A normal A1C alongside an elevated fasting glucose usually occurs when daytime blood sugar is well regulated despite elevated morning readings. Fasting plasma glucose is a snapshot of one morning, so a single value carries the variability of that morning. Because an HbA1c reading averages blood sugar across three months and weighs heavily on overall daytime control, transient morning spikes may not push the three-month average into the prediabetes range. Alternatively, conditions that shorten red blood cell lifespan can artificially depress HbA1c, masking chronic hyperglycemia. When these markers conflict, clinical guidelines recommend evaluating potential interferences rather than relying on one value.
Why is my fasting glucose normal but my A1C high?
An elevated A1C paired with a normal fasting glucose typically indicates postprandial glucose spikes after meals that resolve by morning. A normal fasting glucose confirms that the liver manages baseline glucose release overnight. However, significant blood sugar elevations after meals can raise the cumulative three-month average captured by glycated hemoglobin. Non-glycemic factors can also raise HbA1c without higher blood sugar. Anything that shortens red-cell lifespan lowers A1C without glucose having changed, and anything that lengthens it raises A1C. The ADA Standards of Care in Diabetes 2026 advises evaluating for test interferences or administering an oral glucose tolerance test when this discordance occurs.
Can you be diagnosed with diabetes from one test?
A clinician usually cannot diagnose diabetes from a single test. The American Diabetes Association diagnostic criteria explicitly state that each test usually needs to be repeated on a second day to confirm a diabetes diagnosis. This confirmation can involve repeating the original test or administering a different diagnostic test, such as an oral glucose tolerance test. The only exception occurs when a patient presents with classic symptoms of severe hyperglycemia, such as unintended weight loss, extreme thirst, and frequent urination, alongside a random plasma glucose concentration of 200 mg/dL or higher. In the absence of acute symptoms, formal diagnosis requires two concordant results on separate days.
Do you have to fast for an A1C test?
No, you do not need to fast before an A1C blood draw. Glycated hemoglobin measures glucose attached to hemoglobin inside red blood cells over their approximate three-month lifespan. Because non-enzymatic glycation occurs slowly over weeks, meals consumed on the day of the test do not materially alter the percentage. Fasting plasma glucose, by contrast, requires a fasting period before the draw because recent nutrient intake immediately elevates circulating free glucose. If a clinician orders both tests simultaneously on a standard metabolic panel, you must follow the fasting requirements required by the fasting plasma glucose test.
What conditions make an A1C result unreliable?
Conditions that alter red blood cell turnover or hemoglobin structure make an A1C test unreliable. The ADA Standards of Care in Diabetes 2026 highlights that pregnancy, HIV infection, G6PD deficiency, and conditions affecting erythrocyte lifespan skew HbA1c results. A shortened red-cell lifespan pulls the measured percentage down and a lengthened one pushes it up, independent of ambient glucose. Furthermore, people with sickle cell disease (HbSS) or homozygous hemoglobin variants lack hemoglobin A, making standard A1C measurement impossible. In these scenarios, clinicians must rely on plasma glucose criteria for diagnosis.
Which test is used to diagnose prediabetes?
Both tests are officially approved to diagnose prediabetes under American Diabetes Association criteria, though they capture overlapping rather than identical patient groups. Under ADA standards, an HbA1c of 5.7 percent to 6.4 percent defines prediabetes, while a fasting plasma glucose concentration of 100 to 125 mg/dL defines impaired fasting glucose, also classified as prediabetes. Which test identifies more people with prediabetes varies by population, age and ancestry, which is why the guidelines list them as separate criteria rather than as one. Because one test may detect dysglycemia while the other remains within the normal reference range, clinicians frequently order both markers or use an oral glucose tolerance test to identify metabolic risk.
Should I ask for both tests?
Requesting both tests provides a far more complete picture of your metabolic health than relying on either marker alone. Fasting plasma glucose informs your clinician about your liver's baseline overnight glucose production, while HbA1c reveals your average glycemic exposure over the preceding three months. When both tests agree within the normal range, you can have greater confidence in your glycemic stability. When they conflict, the disagreement alerts your physician to look for early insulin resistance, post-meal glucose spikes, or non-glycemic factors like altered red blood cell turnover. Discussing both markers together allows your doctor to select the most appropriate confirmatory testing protocol.